About Criam
Criam is a company based in Braga (Portugal) founded in 2016. Criam has raised $1.25 million across 4 funding rounds from investors including Brinc, European Union and SOSV. Criam operates in a competitive market with competitors including EKF, LumiraDx, LightDeck Diagnostics, SpinChip and Abaxis, among others.
- Headquarter Braga, Portugal
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.25 M (USD)
in 4 rounds
-
Latest Funding Round
$1.12 M (USD), Grant
Nov 24, 2021
-
Investors
Brinc
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Criam
Criam has successfully raised a total of $1.25M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $1.12 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Criam
Criam has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Brinc, European Union and SOSV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
Venture capital and private debt fund focused on climate, agrifood, health, AI, and multiple sectors
|
Locked | Locked | Locked | |
|
Venture platform bridging entrepreneurs with investors catalyzing innovation into solutions
|
Locked | Locked | Locked |
Investor details for Criam
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Criam
Investment portfolio details for Criam
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Criam
Detailed financials for Criam
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Criam Comparisons
Peer comparison for Criam
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Criam
Criam operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EKF, LumiraDx, LightDeck Diagnostics, SpinChip and Abaxis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Point-of-care and laboratory blood analyzers are developed by EKF.
|
|
| Locked | Locked | Locked |
Cloud based diagnostics platform for point of care diagnosing
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for multiplex assays are developed.
|
|
| Locked | Locked | Locked |
In-vitro diagnostic test cartridges are developed and manufactured via R&D.
|
|
| Locked | Locked | Locked |
Diagnostics company offering a comprehensive line of on-site diagnostic instruments and rapid tests
|
|
| Locked | Locked | Locked |
Medical diagnostics solutions are researched by the laboratory.
|
Detailed competitors of Criam
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Criam
Complete news archive for Criam
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Criam
Criam was founded in 2016.
Criam is headquartered in Braga, Portugal.
Vitor Crespo is the current CEO of Criam.
Criam is a funded company, having raised a total of $1.25M across 4 funding rounds to date.
Founded in 2016 in Braga, Portugal, Criam operates as a medical technology startup. A point-of-care device is being developed based on a novel methodology that combines plate tests with image processing to detect agglutination in blood samples and reagents. The focus is placed on blood phenotyping for emergency response scenarios, aiming to reduce reliance on O-negative blood in critical care settings.
Criam has 6 investors. Key investors include Brinc, European Union, SOSV, Artesian, and Social Impact Fund.